Table 1. Cardiovascular disease indicators for Rwanda.
| Indicators | Male | Female | Total | Year |
| Status of the national CVD epidemic | ||||
| Premature CVD mortality (30–70 years old) (% deaths) | - | 10 | 2012 | |
| Total CVD mortality (% of deaths) | 9.6 | 14.5 | 11.9 (31.8)* | 2017 |
| Total RHD mortality (% of deaths) | 0.14 | 0.2 | 0.17 (.5)* | 2017 |
| Total RHD mortality (% of deaths) | 0.14 | 0.2 | 0.17 (.5)* | 2017 |
| DALYs attributable to CVD (%) | 4.1 | 5.1 | 4.6 (14.7)* | 2017 |
| AF and atrial flutter (%) | 0.13 | 0.12 | 0.12 (.5)* | 2017 |
| Prevalence of RHD (%) | 0.9 | 1.1 | 1.0 (.5)* | 2017 |
| Tobacco and alcohol | ||||
| Prevalence of adult tobacco use (. 15 years old (%)** | 19.1 (36.1)# | 7.1 (6.8)# | - | 2013 |
| Prevalence of youth (13–15-year-olds) tobacco use (%) | 13.3 | 9.5 | 2018 | |
| Estimated direct (healthcare-related) cost of tobacco use in your population (in current US$) | - | - | - | 2018 |
| Proportion of premature CVD mortality attributable to tobacco (%) | - | 1 (10)# | 2004 | |
| Recorded alcohol consumption per capita (. 15 years) (in litres of pure alcohol) (three-year average) | 7.0 | 2016–18 | ||
| Raised blood pressure and cholesterol | ||||
| Population with raised BP (SBP . 140 mmHg or DBP . 90 mmHg) (%)** | 16.8 (24.1)# | 15.0 (20.1)# | 15.9 | 2013 |
| Population with raised TC (. 5.0 mmol/l) (%)** | 2.4 | 3.3 | 2.9 (38.9)# | 2013 |
| DALYs attributable to hypertension (%) | 2.36 | 3.3 | 2.81 (8.7)* | 2017 |
| Mortality caused by hypertensive heart disease (% of deaths) | 0.81 | 2.94 | 1.82 (1.7)* | 2017 |
| Physical activity | ||||
| Adolescents (11–17 years old) who are insufficiently active (< 60 minutes of moderate-to vigorous-intensity PA daily) (%) | - | - | - (80.7)# | 2010 |
| Adults (age-standardised estimate) who are insufficiently active (< 150 minutes of moderate-intensity PA per week, or < 75 minutes of vigorous-intensity PA per week) (%) | 11 | 17.6 | 14.6 (27.5)* | 2016 |
| Overweight and obesity | ||||
| Adults (15.64 years old) who are overweight (BMI . 25.< 30 kg/m2) (%)** | 9.1 | 19.0 | 14.3 (38.9)* | 2013 |
| Prevalence of obesity (BMI . 30 kg/m2) (%)** | 0.8 | 4.7 | 2.8 (13.1)* | 2013 |
| Diabetes | ||||
| Defined population with fasting glucose . 126 mg/dl (7.0 mmol/l) or on medication for raised blood glucose (age-standardised) (%) | 4.3 (9)* | 4.5 (8)* | 4.4 | 2014 |
| Prevalence of diabetes (20–79 years old) (%) | - | - | 5.1 (9.3)## | 2019 |
CVD, cardiovascular disease; RHD, rheumatic heart disease; DALYs, disability-adjusted life years; AF, atrial fibrillation; SBP, systolic blood pressure; DBP,
diastolic blood pressure; TC, total cholesterol; PA, physical activity; BMI, body mass index.
*IHME Global data10
**STEPS data8
#WHO Global data4
##IDF Diabetes Atlas.11